Andrew Pecora, DO
Family Medicine · Marlton, NJNPI 1376637553
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Irhythm Technologies, Inc. accounts for 65.9% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for family medicine clinicians in NJ, where the typical reported total is $394.
Across 5 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Irhythm Technologies, Inc.$70
- Pfizer$24
- Genentech USA, Inc.$12
Across 2 payments — averaging $21,149 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Array Biopharma Inc$42K
What the payments were for
- Food & beverage$106100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Irhythm Technologies, Inc. | 2 | $70 |
| Pfizer | 2 | $24 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$106 in reported general payments places this provider in the 25th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 466 | $147,989 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 13 | $55,167 |
| XareltoRivaroxaban | 66 | $22,596 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $14,626 |
| XifaxanRifaximin | 11 | $14,483 |
| EntrestoSacubitril/Valsartan | 36 | $14,193 |
| Atorvastatin Calcium | 738 | $11,333 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $10,913 |
| Pantoprazole Sodium | 439 | $9,511 |
| JardianceEmpagliflozin | 24 | $9,204 |
| FarxigaDapagliflozin Propanediol | 21 | $8,831 |
| JanuviaSitagliptin Phosphate | 23 | $8,612 |
| LinzessLinaclotide | 14 | $8,005 |
| SantylCollagenase Clostridium Hist. | 23 | $7,698 |
| BrilintaTicagrelor | 31 | $7,454 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $24 | $152,544480 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Marlton
- Matthew PintoMarlton$239K
- Jay PatelMarlton$25K
- Hetal ShahMarlton$18K
- Mikhail VarshavskiChatham$1.4M
- Janet ColeFar Hills$466K
- Jennifer CaudleSewell$226K
- Jeffrey LevineNew Brunswick$195K
- Jennifer AmicoNew Brunswick$159K
- Dena LacaraFairfield$122K
- Gaurang BrahmbhattHoboken$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.